NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Stein E, Clarke JO, Hutfless S, et al. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 110 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. (Future Research Needs Papers, No. 27.)
| Title/ Identifier(s) | Study Dates | Description | Sponsor or Principal Investigator Collaborator(s) | Source |
|---|---|---|---|---|
| Title: Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation Identifier(s): NCT01469819 | Start date: November 2011 Estimated study completion date: December 2012 Estimated primary completion date: December 2012 (Final data collection date for primary outcome measure) | Purpose: To measure the time difference in the duration of transit of the FDA approved SmartPill capsule in all segments of gastrointestinal (GI) tract before and after exposure to lubiprostone. Study design: Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Condition(s): Chronic Idiopathic Constipation Intervention(s): Drug: Lubiprostone Estimated enrollment: 15 | Texas Tech University Health Sciences Center Takeda Pharmaceuticals North America, Inc. | ClinicalTrials Accessed at: clinicaltrials |
| Title: SmartPill Monitoring for Assessment of GI Function in SCI Identifier(s): NCT00856648 | Start date: April 2009 Estimated study completion date: December 2011 Estimated primary completion date: April 2011 (Final data collection date for primary outcome measure) | Purpose: To evaluate the relationship between the level of SCI and the impairment of Colonic transit time (CTT) and Total transit time (TTT) by using the SmartPill device. Study design: Observational Model: Case Control Time Perspective: Prospective Condition(s): SCI Intervention(s): Device: SmartPill ingestion and monitoring Estimated enrollment: 40 | Department of Veterans Affairs | ClinicalTrials Accessed at: clinicaltrials |
| Title: A New Method for Determining Gastric Acid Output Using a Wireless Capsule Identifier(s): NCT00702533 | Start date: June 2008 Estimated study completion date: Ongoing (Currently recruiting participants) Estimated primary completion date: Ongoing (currently recruiting participants) | Purpose: To evaluate the usefulness and accuracy of the SmartPill for gastric analysis, compared with current procedures. Study design: Observational, Time Perspective: Prospective Condition(s): Gastrointestinal Diseases Intervention(s): Wireless Capsule SmartPill Estimated enrollment: 80 | National Institute of Diabetes and Digestive and Kidney Diseases | ClinicalTrials Accessed at: clinicaltrials |
| Title: Evaluation of Gastrointestinal Motility With SmartPill Identifier(s): NCT01159002 | Start date: November 2007 Estimated study completion date: January 2009 Estimated primary completion date: May 2008 (Final data collection date for primary outcome measure) | Purpose: To evaluate the clinical usefulness of a capsule (SmartPill∼) measuring pH, pressure and temperature from within the entire GI tract to determine gastric emptying time, combined small and large bowel transit time and total transit time. Study design: Observational Model: Cohort Time Perspective: Prospective Condition(s): Gastrointestinal Motility Intervention(s): Device: SmartPill Estimated enrollment: 8 | University of Louisville | ClinicalTrials Accessed at: clinicaltrials |